6533b82cfe1ef96bd128fe7d

RESEARCH PRODUCT

Why Do We Have to Use Chemotherapy?

Noelia TarazonaMarisol HuertaAndrés CervantesValentina Gambardella

subject

medicine.medical_specialtyChemotherapymedicine.diagnostic_testbusiness.industryColorectal cancermedicine.medical_treatmentMagnetic resonance imagingmedicine.diseaseOccultRadiation therapyNeoadjuvant treatmentLocally advanced diseaseConcomitantMedicineRadiologybusiness

description

The use of chemotherapy (CT) in localized rectal cancer (LARC) has two aims: first, to improve the local effect of radiotherapy by giving concomitant chemoradiation and second, to decrease systemic relapses by early treatment for occult micrometastatic disease or to shrink bulky local tumours. Neoadjuvant treatment is reserved for locally advanced disease, as defined by pelvic magnetic resonance imaging, a very useful and accurate tool to identify high-risk features for local or systemic relapse [1]. We are going to address why we have to use CT in LARC.

yearjournalcountryeditionlanguage
2018-01-01
https://doi.org/10.1007/978-3-319-43217-5_33